T1	Participants 103 121	healthy volunteers
T2	Participants 611 676	Healthy male and female volunteers aged 18-75 years were included
T3	Participants 678 765	All volunteers received ASA 81 mg once daily for 5 days prior to the study (pre-screen)
T4	Participants 767 904	Subjects were eligible for inclusion if they had aspirin reactivity units (ARU, as measured by the VerifyNow ASA assay) of <550 on Day 6.
T5	Participants 1439 1559	A total of 29 volunteers (19 aged â‰¥50 years; 8 women; 21 men) were evaluable for pharmacodynamic analysis (per protocol)
